When was Neurogen Biomarking founded?

Neurogen Biomarking was founded in 2024.

Where is Neurogen Biomarking located?

Neurogen Biomarking is headquartered in Chicago, United States.

How many employees does Neurogen Biomarking have?

As of Sep 30, 2026, the latest employee count at Neurogen Biomarking is 6.

Where does Neurogen Biomarking rank among its competitors?

Neurogen Biomarking ranks 17th amongst 174 active competitors, of which 28 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was NEUROPHET, which secured $21.5M in Apr, 2026.

Who are the top competitors of Neurogen Biomarking?

Neurogen Biomarking's top competitors include BrainCheck, NEUROPHET and Linus Health. Among them, NEUROPHET secured the most recent funding round in April, 2026.

Neurogen Biomarking - 2026 Company Profile & Competitors

Neurogen Biomarking is an unfunded company based in Chicago (United States), founded in 2024. It operates as a Digital health company dedicated to the early detection of Alzheimer's disease and Mild Cognitive Impairment. Neurogen Biomarking has not raised any funding yet. The company has 174 active competitors, including 28 funded and 10 that have exited. Its top competitors include companies like BrainCheck, NEUROPHET and Linus Health.

Company Details

Digital health company dedicated to the early detection of Alzheimer's disease and Mild Cognitive Impairment. It offers a comprehensive, patient-initiated platform that empowers individuals to monitor and manage their cognitive health.

Website: neurogenbiomarking.com
Email ID: *****@neurogenbiomarking.com

Key Metrics

Founded Year

2024

Location

Chicago, United States

Stage

Unfunded

Ranked

17^th among 174 active competitors

Employee Count

6 as on Sep 30, 2026

Similar Companies

BrainCheck & 197 more

View Neurogen Biomarking's full profile

Neurogen Biomarking has not raised any funding rounds yet.

Neurogen Biomarking's employee count trend

Neurogen Biomarking has 6 employees as of Sep 26. Here is Neurogen Biomarking's employee count trend over the years:

Employee count trend for Neurogen Biomarking

Uncover Neurogen Biomarking's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Neurogen Biomarking include BrainCheck, NEUROPHET and Linus Health. Here is the list of Top 10 competitors of Neurogen Biomarking, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BrainCheck 2014, Houston (United States), Series A	Mobile games for cognitive health tracking	$49.8M	S3 Ventures, Next Coast Ventures & 17 others	65/100
2nd	NEUROPHET 2016, Seoul (South Korea), Public	Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation	$24.4M	ES Investor, SBI Investment Korea & 20 others	63/100
3rd	Linus Health 2019, Boston (United States), Series B	Provider of digital cognitive assessment platform and brain health management tools	$64.9M	Morningside, Agetech Capital & 1 others	60/100
4th	Thymia 2020, Hereford (United Kingdom), Seed	AI-based video games for patient's psychological and mental health assessment	$3.8M	Kodori, Calm/Storm & 12 others	59/100
5th	Altoida 2016, Lucerne (Switzerland), Series A	Provider of a AI-based app which can predict the onset of Alzheimer's	$21.5M	M Ventures, Hikma Ventures & 12 others	56/100
6th	Cambridge Cognition 2002, Cambridge (United Kingdom), Public	Computerized neuropsychological tests for cognitive assessment	-	First Star Ventures, Psion Partners	51/100
7th	VoxNeuro 2017, Hamilton (Canada), Series A	Developer of brain injury and concussion assessment system	$519K	Bay Area Health Trust, The Forge & 4 others	51/100
8th	Cogstate 1999, New Haven (United States), Public	Cognitive assessment solutions for clinical trials, healthcare, and research	-	GBS, Eisai Innovation & 2 others	49/100
9th	NeuroAgeTX 2022, San Francisco (United States), Seed	AI-powered platform revolutionize testing approach for brain health and cognitive function assessments	-	The Gates Notes, IA Seed Adventures & 4 others	44/100
10th	Jvion 2011, Suwanee (United States), Acquired	Provider of a deep learning-based solution for predicting illness	$11.1M	Trinity Health, JMI Management & 7 others	43/100
17th	Neurogen Biomarking 2024, Chicago (United States), Unfunded	Digital health company dedicated to the early detection of Alzheimer's disease and Mild Cognitive Impairment	-	-	40/100